Univariate and multivariate analysis of patients with DLBCL
| Characteristics . | Total (n) . | Univariate analysis . | Multivariate analysis . | ||
|---|---|---|---|---|---|
| Hazard ratio (95% CI) . | P value . | Hazard ratio (95% CI) . | P value . | ||
| Gender | 71 | ||||
| Male | 45 | Reference | |||
| Female | 26 | 0.723 (0.263-1.985) | .529 | ||
| Age | 71 | 1.045 (1.001-1.092) | .046 | 1.054 (1.008-1.103) | .022 |
| MYC/BCL2 expression | 71 | ||||
| Non-DE | 29 | Reference | |||
| DE | 42 | 1.659 (0.620-4.435) | .313 | ||
| p-S6 expression | 71 | ||||
| Low | 22 | Reference | |||
| High | 49 | 4.913 (1.118-21.585) | .035 | 5.758 (1.297-25.558) | .021 |
| Hans | 68 | ||||
| Non-GCB | 45 | Reference | |||
| GCB | 23 | 1.255 (0.454-3.469) | .662 | ||
| Ann Arbor stage | 71 | ||||
| Ⅰ | 10 | Reference | |||
| Ⅱ | 12 | 75 715 781.210 (0.000 to Inf) | .998 | ||
| Ⅲ | 9 | 203 509 622.443 (0.000 to Inf) | .998 | ||
| Ⅳ | 40 | 406 929 403.918 (0.000 to Inf) | .998 | ||
| Characteristics . | Total (n) . | Univariate analysis . | Multivariate analysis . | ||
|---|---|---|---|---|---|
| Hazard ratio (95% CI) . | P value . | Hazard ratio (95% CI) . | P value . | ||
| Gender | 71 | ||||
| Male | 45 | Reference | |||
| Female | 26 | 0.723 (0.263-1.985) | .529 | ||
| Age | 71 | 1.045 (1.001-1.092) | .046 | 1.054 (1.008-1.103) | .022 |
| MYC/BCL2 expression | 71 | ||||
| Non-DE | 29 | Reference | |||
| DE | 42 | 1.659 (0.620-4.435) | .313 | ||
| p-S6 expression | 71 | ||||
| Low | 22 | Reference | |||
| High | 49 | 4.913 (1.118-21.585) | .035 | 5.758 (1.297-25.558) | .021 |
| Hans | 68 | ||||
| Non-GCB | 45 | Reference | |||
| GCB | 23 | 1.255 (0.454-3.469) | .662 | ||
| Ann Arbor stage | 71 | ||||
| Ⅰ | 10 | Reference | |||
| Ⅱ | 12 | 75 715 781.210 (0.000 to Inf) | .998 | ||
| Ⅲ | 9 | 203 509 622.443 (0.000 to Inf) | .998 | ||
| Ⅳ | 40 | 406 929 403.918 (0.000 to Inf) | .998 | ||
Bold: classification of patients with DLBCL; CI, confidence interval; Inf, infinity